Methylnaltrexone in the treatment of opioid-induced constipation

References

• LangLThe Food and Drug Administration approves methylnaltrexone bromide for opioid-induced constipationGastroenterology200813516
   Web of Science ®Google Scholar
• ManaraLBianchettiAThe central and peripheral influence of opioids on gastrointestinal propulsionAnnu Rev Pharmacol Toxicol1985252492733890704
   PubMed Web of Science ®Google Scholar
• ManaraLBianchiGFerrettiPTavaniAInhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on the gut opioid sitesJ Pharmacol Exp Ther198623739459493012075
   PubMed Web of Science ®Google Scholar
• SterniniCReceptors and transmission in the brain-gut axis: potential for novel therapies. III. Mu-opioid receptors in the enteric nervous systemAm J Physiol Gastrointest Liver Physiol20012811G8G1511408250
   PubMed Web of Science ®Google Scholar
• SterniniCPatiernoSSelmerISKirchgessnerAThe opioid system in the gastrointestinal tractNeurogastroenterol Motil200416Suppl 231615357847
   PubMed Web of Science ®Google Scholar
• DeHaven-HudkinsDLDeHavenRNLittlePJTechnerLMThe involvement of the mu-opioid receptor in gastrointestinal patho-physiology: therapeutic opportunities for antagonism at this receptorPharmacol Ther2008117116218718022696
   PubMed Web of Science ®Google Scholar
• TrendelenburgP[Physiological and pharmacological investigations of small intestinal peristalsis]Naunyn Schmiedebergs Arch Pharmacol191781155129
   Google Scholar
• SangerGJTuladharBRThe role of endogenous opioids in the control of gastrointestinal motility: prediction from in vitro modellingNeurogastroenterol Motil200416Suppl 2384515357850
   PubMed Web of Science ®Google Scholar
• OomsLADegryseADJanssenPAMechanisms of action of loperamideScand J Gastroenterol Suppl1984961451556382576
   PubMedGoogle Scholar
• BuenoLFioramontiJAction of opiates on gastrointestinal functionBaillieres Clin Gastroenterol1988211231392838107
   PubMed Web of Science ®Google Scholar
• WoodJDGalliganJJFunction of opioids in the enteric nervous systemNeurogastroenterol Motil200416Suppl 2172815357848
   PubMed Web of Science ®Google Scholar
• ToniniMWatermanSACanduraSMCocciniTCostaMSites of action of morphine on the ascending excitatory reflex in the guinea-pig small intestineNeurosci Lett19921441–21951981331912
   PubMed Web of Science ®Google Scholar
• AllescherHDStorrMBrechmannCHahnASchusdziarraVModulatory effect of endogenous and exogenous opioids on the excitatory reflex pathway of the rat ileumNeuropeptides2000341626810688971
   PubMed Web of Science ®Google Scholar
• KojimaYTakahashiTFujinaMOwyangCInhibition of cholinergic transmission by opiates in ileal myenteric plexus is mediated by kappa receptor. Involvement of regulatory inhibitory G protein and calcium N-channelsJ Pharmacol Exp Ther199426829659708114012
   PubMed Web of Science ®Google Scholar
• HoyleCHKammMABurnstockGLennard-JonesJEEnkephalins modulate inhibitory neuromuscular transmission in circular muscle of human colon via delta-opioid receptorsJ Physiol19904314654781966052
   PubMed Web of Science ®Google Scholar
• ZagorodnyukVMaggiCAElectrophysiological evidence for different release mechanism of ATP and NO as inhibitory NANC transmitters in guinea-pig colonBr J Pharmacol19941124107710827952866
   PubMed Web of Science ®Google Scholar
• De LucaACouparIMInsights into opioid action in the intestinal tractPharmacol Ther19966921031158984506
   PubMed Web of Science ®Google Scholar
• FriedmanJDDello BuonoFAOpioid antagonists in the treatment of opioid-induced constipation and pruritusAnn Pharmacother2001351859111197589
   PubMed Web of Science ®Google Scholar
• Greenwood-Van MeerveldBGardnerCJLittlePJHicksGADeHaven-HudkinsDLPreclinical studies of opioids and opioid antagonists on gastrointestinal functionNeurogastroenterol Motil200416Suppl 2465315357851
   PubMed Web of Science ®Google Scholar
• PappagalloMIncidence, prevalence and management of opioid bowel dysfunctionAm J Surg20011825A Suppl11S18S11755892
   PubMed Web of Science ®Google Scholar
• ThomasJOpioid-induced bowel dysfunctionJ Pain Symptom Manage200835110311317981003
   PubMed Web of Science ®Google Scholar
• FossJFA review of the potential role of methylnaltrexone in opioid bowel dysfunctionAm J Surg20011825A Suppl19S26S11755893
   PubMed Web of Science ®Google Scholar
• McNicolEDBoyceDSchumannRCarrDBMu-opioid antagonists for opioid-induced bowel dysfunctionCochrane Database Syst Rev20082CD00633218425947
   PubMed Web of Science ®Google Scholar
• WalshTDPrevention of opioid side effectsJ Pain Symptom Manage1990563623671980127
   PubMedGoogle Scholar
• GlarePLickissJNUnrecognized constipation in patients with advanced cancer: a recipe for therapeutic disasterJ Pain Symptom Manage1992763693711517653
   PubMed Web of Science ®Google Scholar
• SwegleJMLogemannCManagement of common opioid-induced adverse effectsAm Fam Physician20067481347135417087429
   PubMed Web of Science ®Google Scholar
• LagmanRLDavisMPLeGrandSBWalshDCommon symptoms in advanced cancerSurg Clin North Am200585223725515833469
   PubMed Web of Science ®Google Scholar
• RussellJBassPGoldbergLISchusterCRMerzHAntagonism of gut, but not central effects of morphine with quaternary narcotic antagonistsEur J Pharmacol19827832552617200037
   PubMed Web of Science ®Google Scholar
• BrownDRGoldbergLIThe use of quaternary narcotic antagonists in opiate researchNeuropharmacology19852431811912986035
   PubMed Web of Science ®Google Scholar
• ValentinoRJHerlingSWoodsJHMedzihradskyFMerzHQuaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonistsJ Pharmacol Exp Ther198121736526596262493
   PubMed Web of Science ®Google Scholar
• BeattieDTCheruvuMMaiNThe in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexoneNaunyn Schmiedebergs Arch Pharmacol2007375320522017340127
   PubMed Web of Science ®Google Scholar
• YuanCSFossJFMossJEffects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestineEur J Pharmacol19952761–21071117781680
   PubMed Web of Science ®Google Scholar
• Van HoogmoedLMBoscanPLIn vitro evaluation of the effect of the opioid antagonist N-methylnaltrexone on motility of the equine jejunum and pelvic flexureEquine Vet J200537432532816028621
   PubMed Web of Science ®Google Scholar
• GmerekDECowanAWoodsJHIndependent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in ratsJ Pharmacol Exp Ther198623618133941402
   PubMed Web of Science ®Google Scholar
• WalkerMJLeADPoulosCXCappellHRole of central versus peripheral opioid receptors in analgesia induced repeated administration of opioid antagonistsPsychopharmacology (Berl)199110421641661652143
   PubMed Web of Science ®Google Scholar
• ValentinoRJKatzJLMedzihradskyFWoodsJHReceptor binding, antagonist, and withdrawal precipitating properties of opiate antagonistsLife Sci19833225288728966304445
   PubMed Web of Science ®Google Scholar
• FossJFO’ConnorMFYuanCSMurphyMMossJRoizenMFSafety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic studyJ Clin Pharmacol199737125309048269
   PubMed Web of Science ®Google Scholar
• YuanCSFossJFO’ConnerMToledanoARoizenMFMossJMethylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trialClin Pharmacol Ther19965944694758612393
   PubMed Web of Science ®Google Scholar
• YuanCSWeiGFossJFO’ConnorMKarrisonTOsinskiJEffects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trialJ Pharmacol Exp Ther2002300111812311752106
   PubMed Web of Science ®Google Scholar
• YuanCSFossJFO’ConnorMOsinskiJRoizenMFMossJEfficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphineDrug Alcohol Depend19985221611659800145
   PubMed Web of Science ®Google Scholar
• Full Prescribing Information [linked PDF, cited 2008 Nov 14]. Available from: http://www.wyeth.com/hcp/relistor/landing.
   Google Scholar
• YuanCSFossJFO’ConnorMOsinskiJRoizenMFMossJEffects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot studyPain199983363163510568873
   PubMed Web of Science ®Google Scholar
• YuanCSFossJFO’ConnorMMethylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trialJAMA2000283336737210647800
   PubMed Web of Science ®Google Scholar
• YuanCSFossJFO’ConnorMEffects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit timeClin Pharmacol Ther200067439840410801249
   PubMed Web of Science ®Google Scholar
• MurphyDBSuttonJAPrescottLFMurphyMBOpioid-induced delay in gastric emptying: a peripheral mechanism in humansAnesthesiology19978747657709357876
   PubMed Web of Science ®Google Scholar
• YuanCSFossJFOsinskiJToledanoARoizenMFMossJThe safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit timeClin Pharmacol Ther19976144674759129564
   PubMed Web of Science ®Google Scholar
• PortenoyRKThomasJMoehl BoatwrightMLSubcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging studyJ Pain Symptom Manage200835545846818440447
   PubMed Web of Science ®Google Scholar
• ThomasJKarverSCooneyGAMethylnaltrexone for opioid-induced constipation in advanced illnessN Engl J Med2008358222332234318509120
   PubMed Web of Science ®Google Scholar
• Greenwood-Van MeerveldBEmerging drugs for postoperative ileusExpert Opin Emerg Drugs200712461962617979603
   PubMed Web of Science ®Google Scholar
• SenagoreAJOverview of POI and its impact on surgical outcomesContemporary Surg20063Suppl47
   Google Scholar
• ArtinyanANunoo-MensahJWBalasubramaniamSProlonged postoperative ileus-definition, risk factors and predictors after surgeryWorld J Surg20083271495150018305994
   PubMed Web of Science ®Google Scholar
• BauerAJBoeckxstaensGEMechanisms of postoperative ileusNeurogastroenterol Motil200416Suppl 2546015357852
   PubMed Web of Science ®Google Scholar
• SagradaAFargeasMJBuenoLInvolvement of alpha-1 and alpha-2 adrenoceptors in the postlaparotomy intestinal motor disturbances in the ratGut19872889559592889649
   PubMed Web of Science ®Google Scholar
• BoeckxstaensGEHirschDPKoddeAActivation of an adrenergic and vagally mediated NANC pathway in surgery-induced fundic relaxation in the ratNeurogastroenterol Motil199911646747410583854
   PubMed Web of Science ®Google Scholar
• HolzerPLippeITAmannRParticipation of capsaicin-sensitive afferent neurons in gastric motor inhibition caused by laparotomy and intraperitoneal acidNeuroscience19924837157221603337
   PubMed Web of Science ®Google Scholar
• BarquistEBonazBMartinezVRivierJZinnerMJTacheYNeuronal pathways involved in abdominal surgery-induced gastric ileus in ratsAm J Physiol19962704 Pt 2R888R8948967419
   PubMed Web of Science ®Google Scholar
• BonazBTacheYCorticotropin-releasing factor and systemic capsaicin-sensitive afferents are involved in abdominal surgery-induced Fos expression in the paraventricular nucleus of the hypothalamusBrain Res19977481–212209067440
   PubMed Web of Science ®Google Scholar
• TacheYMonnikesHBonazBRivierJRole of CRF on stress-related alterations of gastric and colonic motor functionAnn N Y Acad Sci19936972332438257013
   PubMed Web of Science ®Google Scholar
• De WinterBYBoeckxstaensGEDe ManJGMoreelsTGHermanAGPelckmansPAEffect of adrenergic and nitrergic blockade on experimental ileus in ratsBr J Pharmacol199712034644689031750
   PubMed Web of Science ®Google Scholar
• De WinterBYRobberechtPBoeckxstaensGERole of VIP1/PACAP receptors in postoperative ileus in ratsBr J Pharmacol19981246118111869720789
   PubMed Web of Science ®Google Scholar
• BoeckxstaensGEHollmannMHeisterkampSHEvidence for VIP(1)/PACAP receptors in the afferent pathway mediating surgery-induced fundic relaxation in the ratBr J Pharmacol2000131470571011030719
   PubMed Web of Science ®Google Scholar
• KälffJCTürlerASchwarzNTIntra-abdominal activation of a local inflammatory response within the human muscularis externa during laparotomyAnn Surg2003237330131512616113
   PubMed Web of Science ®Google Scholar
• SchwarzNTBeer-StolzDSimmonsRLBauerAJPathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularisAnn Surg20022351314011753040
   PubMed Web of Science ®Google Scholar
• De JongeWJTheFOvan der ZandenEPvan den WijngaardRMBoeckxstaensGEInflammation and gut motility; neural control of intestinal immune cell activationJ Pediatr Gastroenterol Nutr200541Suppl 1S10S1116131950
   PubMed Web of Science ®Google Scholar
• KälffJCCarlosTMSchrautWHBilliarTRSimmonsRLBauerAJSurgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileusGastroenterology1999117237838710419919
   PubMed Web of Science ®Google Scholar
• TheFOde JongeWJBenninkRJvan der WijngaardRMBoeckxstaensGEThe ICAM-1 antisense oligonucleotide ISIS-3082 prevents the development of postoperative ileus in miceBr J Pharmacol2005146225225815997238
   PubMed Web of Science ®Google Scholar
• KälffJCBuchholzBMEskandariMKBiphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in ratsSurgery1999126349850910486602
   PubMed Web of Science ®Google Scholar
• TurlerAMooreBAPezzoneMAOverhausMKalffJCBauerAJColonic postoperative inflammatory ileus in the ratAnn Surg20022361566612131086
   PubMed Web of Science ®Google Scholar
• KreissCToegelSBauerAJAlpha2-adrenergic regulation of NO production alters postoperative intestinal smooth muscle dysfunction in rodentAm J Physiol Gastrointest Liver Physiol20042873G65866615331355
   PubMed Web of Science ®Google Scholar
• ViscusiERathmellJFicheraAGanTLIsraelRJA double-blind, randomized, placebo-controlled trial of methylnaltrexone (MNTX) for post-operative bowel dysfunction in segmental colectomy patients [abstract]Am Soc Anesth2005103A893
   Google Scholar
• KraftMDMethylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileusExpert Opin Investig Drugs200817913651377
   PubMed Web of Science ®Google Scholar
• Tan-NoKNiijimaFNakagawasaiOSatoTSatohSTadanoTDevelopment of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in miceEur J Pharm Sci200320335736314592702
   PubMed Web of Science ®Google Scholar
• HoEAPiquette-MillerMRegulation of multidrug resistance by pro-inflammatory cytokinesCurr Cancer Drug Targets20066429531116848721
   PubMed Web of Science ®Google Scholar
• IizasaHGendaNKitanoTAltered expression and function of P-glycoprotein in dextran sodium sulfate-induced colitis in miceJ Pharm Sci200392256957612587118
   PubMed Web of Science ®Google Scholar
• HartmannGKimHPiquette-MillerMRegulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in miceInt Immunopharmacol20011218919911360920
   PubMed Web of Science ®Google Scholar
• HeemskerkSvan KoppenAvan den BroekLNitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemiaPflugers Arch2007454232133417285300
   PubMed Web of Science ®Google Scholar